MannKind Corp. (MNKD)
4.055
+0.10
(+2.40%)
USD |
NASDAQ |
Sep 04, 16:00
4.03
-0.02
(-0.62%)
After-Hours: 19:16
MannKind Cash and Short Term Investments (Annual) : 171.35M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 171.35M |
| December 31, 2024 | 197.26M |
| December 31, 2023 | 295.10M |
| December 31, 2022 | 170.85M |
| December 31, 2021 | 204.12M |
| December 31, 2020 | 67.16M |
| December 31, 2019 | 50.20M |
| December 31, 2018 | 71.68M |
| December 31, 2017 | 48.36M |
| December 31, 2016 | 23.24M |
| December 31, 2015 | 59.07M |
| December 31, 2014 | 120.84M |
| December 31, 2013 | 70.79M |
| Date | Value |
|---|---|
| December 31, 2012 | 61.84M |
| December 31, 2011 | 3.196M |
| December 31, 2010 | 70.43M |
| December 31, 2009 | 32.49M |
| December 31, 2008 | 46.49M |
| December 31, 2007 | 368.28M |
| December 31, 2006 | 436.48M |
| December 31, 2005 | 145.63M |
| December 31, 2004 | 91.12M |
| December 31, 2003 | 138.39M |
| December 31, 2002 | 31.05M |
| December 31, 2001 | 53.73M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| United Therapeutics Corp. | 2.920B |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Gilead Sciences, Inc. | 9.613B |
| Vertex Pharmaceuticals, Inc. | 6.611B |
| Ocugen, Inc. | 18.57M |